CRNX Insider Trading

Insider Ownership Percentage: 6.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $26,278,027.53

Crinetics Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Crinetics Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Crinetics Pharmaceuticals Share Price & Price History

Current Price: $54.72
Price Change: Price Decrease of -4.94 (-8.28%)
As of 11/15/2024 01:00 AM ET

This chart shows the closing price history over time for CRNX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Crinetics Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/3/2024Dana PizzutiInsiderSell14,375$54.63$785,306.2528,507View SEC Filing Icon  
9/26/2024Marc WilsonCFOSell25,000$51.11$1,277,750.00111,092View SEC Filing Icon  
9/10/2024Stephen F. BetzInsiderSell1,035$51.50$53,302.5068,576View SEC Filing Icon  
8/26/2024Stephen F. BetzInsiderSell3,000$53.19$159,570.0069,611View SEC Filing Icon  
7/25/2024Marc WilsonCFOSell19,056$53.88$1,026,737.28111,092View SEC Filing Icon  
7/25/2024Stephen F. BetzInsiderSell3,000$53.43$160,290.0075,611View SEC Filing Icon  
7/15/2024Jeff E. KnightCOOSell27,000$55.00$1,485,000.0051,653View SEC Filing Icon  
7/15/2024Marc WilsonCFOSell25,000$55.00$1,375,000.00111,092View SEC Filing Icon  
7/10/2024Stephen F. BetzInsiderSell3,000$48.55$145,650.0078,611View SEC Filing Icon  
7/5/2024James HassardInsiderSell15,000$44.08$661,200.0029,259View SEC Filing Icon  
7/3/2024Dana PizzutiInsiderSell14,375$44.87$645,006.2528,507View SEC Filing Icon  
6/28/2024Marc WilsonCFOSell32,129$43.61$1,401,145.69111,092View SEC Filing Icon  
6/26/2024Jeff E. KnightCOOSell956$44.38$42,427.2852,580View SEC Filing Icon  
6/24/2024Dana PizzutiInsiderSell9,500$45.73$434,435.0027,786View SEC Filing Icon  
6/21/2024James HassardInsiderSell15,000$44.66$669,900.0029,259View SEC Filing Icon  
6/10/2024Stephen F. BetzInsiderSell3,000$43.86$131,580.0083,643View SEC Filing Icon  
5/28/2024Stephen F. BetzInsiderSell3,000$47.49$142,470.0086,643View SEC Filing Icon  
5/10/2024Stephen F. BetzInsiderSell3,000$49.43$148,290.0089,643View SEC Filing Icon  
5/8/2024Richard Scott StruthersCEOSell107,448$49.40$5,307,931.20257,485View SEC Filing Icon  
4/15/2024Dana PizzutiInsiderSell14,375$44.47$639,256.2527,786View SEC Filing Icon  
4/4/2024Richard Scott StruthersCEOSell40,951$49.17$2,013,560.67237,835View SEC Filing Icon  
3/28/2024Stephanie OkeyDirectorSell17,500$46.38$811,650.006,000View SEC Filing Icon  
3/22/2024Jeff E. KnightCOOSell32,359$44.31$1,433,827.2952,580View SEC Filing Icon  
3/20/2024Dana PizzutiInsiderSell15,089$44.06$664,821.3427,786View SEC Filing Icon  
3/20/2024Matthew K. FustDirectorSell60,000$44.14$2,648,400.0018,536View SEC Filing Icon  
3/19/2024Marc WilsonCFOSell6,942$42.91$297,881.22110,630View SEC Filing Icon  
1/25/2024Stephen F. BetzInsiderSell3,000$37.26$111,780.0073,298View SEC Filing Icon  
1/10/2024Stephen F. BetzInsiderSell3,000$37.65$112,950.0076,298View SEC Filing Icon  
1/3/2024Dana PizzutiInsiderSell14,375$35.00$503,125.005,911View SEC Filing Icon  
1/2/2024Marc WilsonCFOSell10,000$35.47$354,700.0096,055View SEC Filing Icon  
12/26/2023Stephen F. BetzInsiderSell3,000$35.89$107,670.0079,298View SEC Filing Icon  
12/21/2023Dana PizzutiInsiderSell9,583$34.57$331,284.315,911View SEC Filing Icon  
12/11/2023Stephen F. BetzInsiderSell3,000$32.87$98,610.0082,298View SEC Filing Icon  
11/27/2023Stephen F. BetzInsiderSell3,000$31.84$95,520.0085,298View SEC Filing Icon  
11/3/2023Richard Scott StruthersCEOSell199,082$30.56$6,083,945.92135,522View SEC Filing Icon  
11/1/2023Marc WilsonCFOSell10,000$28.75$287,500.0095,601View SEC Filing Icon  
10/17/2023Alan Seth KrasnerInsiderSell7,000$30.00$210,000.0043,210View SEC Filing Icon  
7/13/2023Richard Scott StruthersCEOSell14,157$20.35$288,094.95630,805View SEC Filing Icon  
7/11/2023Richard Scott StruthersCEOSell24,384$20.14$491,093.76656,421View SEC Filing Icon  
6/20/2023Marc WilsonCFOSell30,922$19.97$617,512.3495,158View SEC Filing Icon  
6/16/2023Richard Scott StruthersCEOSell50,000$20.81$1,040,500.00680,805View SEC Filing Icon  
6/8/2023Coelho Rogerio VivaldiDirectorBuy5,000$22.06$110,300.005,000View SEC Filing Icon  
4/5/2023Dana PizzutiInsiderSell8,212$16.15$132,623.804,500View SEC Filing Icon  
1/25/2023Stephen F. BetzInsiderSell8,336$21.07$175,639.5267,815View SEC Filing Icon  
1/17/2023Stephen F. BetzInsiderSell3,126$18.00$56,268.0076,151View SEC Filing Icon  
12/15/2022Stephen F. BetzInsiderSell3,126$16.00$50,016.0082,403View SEC Filing Icon  
12/1/2022Stephen F. BetzInsiderSell3,126$17.84$55,767.8484,968View SEC Filing Icon  
11/15/2022Stephen F. BetzInsiderSell3,126$18.72$58,518.7288,094View SEC Filing Icon  
10/17/2022Stephen F. BetzInsiderSell3,126$17.73$55,423.9894,346View SEC Filing Icon  
10/3/2022Stephen F. BetzInsiderSell3,126$19.64$61,394.6497,472View SEC Filing Icon  
9/15/2022Stephen F. BetzInsiderSell4,168$21.01$87,569.68100,598View SEC Filing Icon  
9/7/2022Stephen F. BetzInsiderSell1,042$21.00$21,882.00104,766View SEC Filing Icon  
7/26/2022Jeff E. KnightCOOSell1,152$20.70$23,846.404,950View SEC Filing Icon  
7/13/2022Matthew K. FustDirectorSell5,700$20.96$119,472.0012,536View SEC Filing Icon  
5/2/2022Stephen F. BetzInsiderSell3,247$20.10$65,264.70107,598View SEC Filing Icon  
4/18/2022Perceptive Advisors LlcMajor ShareholderBuy157,515$22.22$3,499,983.305,321,032View SEC Filing Icon  
4/18/2022Stephen F. BetzInsiderSell5,664$25.81$146,187.84110,845View SEC Filing Icon  
4/13/2022Richard Scott StruthersCEOSell138,643$26.83$3,719,791.69730,805View SEC Filing Icon  
4/5/2022Richard Scott StruthersCEOSell21,357$25.34$541,186.3857,400View SEC Filing Icon  
4/4/2022Stephen F. BetzInsiderSell9,000$23.97$215,730.00116,509View SEC Filing Icon  
3/31/2022Stephen F. BetzInsiderSell4,164$21.06$87,693.84View SEC Filing Icon  
3/1/2022Stephen F. BetzInsiderSell3,123$19.73$61,616.79View SEC Filing Icon  
2/7/2022Ajay MadanInsiderSell13,411$17.83$239,118.13View SEC Filing Icon  
2/1/2022Stephen F. BetzInsiderSell3,123$18.79$58,681.17View SEC Filing Icon  
1/18/2022Stephen F. BetzInsiderSell4,168$23.29$97,072.72View SEC Filing Icon  
1/3/2022Stephen F. BetzInsiderSell7,168$28.02$200,847.36View SEC Filing Icon  
12/28/2021Stephen F. BetzInsiderSell3,000$27.95$83,850.00View SEC Filing Icon  
12/15/2021Stephen F. BetzInsiderSell5,668$24.14$136,825.52View SEC Filing Icon  
12/1/2021Stephen F. BetzInsiderSell5,668$27.38$155,189.84View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Crinetics Pharmaceuticals (NASDAQ:CRNX)

98.51% of Crinetics Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CRNX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Crinetics Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2024Geode Capital Management LLC1,848,133$94.46M0.0%+10.1%1.993%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC207,712$10.61M0.0%+75.5%0.224%Search for SEC Filing on Google Icon
11/15/2024Pier Capital LLC108,361$5.54M0.8%-0.2%0.117%Search for SEC Filing on Google Icon
11/15/2024Orion Portfolio Solutions LLC18,236$0.93M0.0%-4.2%0.020%Search for SEC Filing on Google Icon
11/15/2024Castleark Management LLC73,340$3.75M0.2%N/A0.079%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC129,592$6.62M0.0%-4.1%0.140%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP4,459,691$227.89M0.0%-3.5%4.809%Search for SEC Filing on Google Icon
11/15/2024State Street Corp2,838,484$145.05M0.0%+0.9%3.061%Search for SEC Filing on Google Icon
11/15/2024Stifel Financial Corp10,038$0.51M0.0%-4.9%0.011%Search for SEC Filing on Google Icon
11/15/2024Point72 Asset Management L.P.2,300,643$117.56M0.3%-17.3%2.481%Search for SEC Filing on Google Icon
11/15/2024Parkman Healthcare Partners LLC77,623$3.97M0.5%-45.1%0.084%Search for SEC Filing on Google Icon
11/15/2024Ikarian Capital LLC426,913$21.82M2.9%-27.5%0.460%Search for SEC Filing on Google Icon
11/15/2024Janus Henderson Group PLC2,429,450$124.13M0.1%-1.1%2.620%Search for SEC Filing on Google Icon
11/15/2024HighVista Strategies LLC28,911$1.48M0.5%-18.0%0.031%Search for SEC Filing on Google Icon
11/15/2024Cinctive Capital Management LP49,445$2.53M0.1%N/A0.053%Search for SEC Filing on Google Icon
11/14/2024Vestal Point Capital LP205,000$10.48M0.8%N/A0.256%Search for SEC Filing on Google Icon
11/14/2024Martingale Asset Management L P22,074$1.13M0.0%N/A0.028%Search for SEC Filing on Google Icon
11/14/2024PEAK6 Investments LLC10,000$0.51M0.0%+25.0%0.012%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC271,747$13.89M0.0%+4.1%0.340%Search for SEC Filing on Google Icon
11/14/2024Acuta Capital Partners LLC131,700$6.73M5.5%-2.5%0.165%Search for SEC Filing on Google Icon
11/13/2024Glenmede Trust Co. NA17,144$0.88M0.0%-4.5%0.021%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets20,942$1.07M0.0%+134.2%0.026%Search for SEC Filing on Google Icon
11/13/2024Advantage Alpha Capital Partners LP8,640$0.44M0.1%N/A0.011%Search for SEC Filing on Google Icon
11/13/2024FMR LLC4,455,770$227.69M0.0%+8.8%5.567%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company 134,087$6.85M0.0%+2.3%0.168%Search for SEC Filing on Google Icon
11/13/2024Fisher Asset Management LLC482,099$24.64M0.0%+8.4%0.602%Search for SEC Filing on Google Icon
11/12/2024Algert Global LLC42,777$2.19M0.1%+2.6%0.053%Search for SEC Filing on Google Icon
11/12/2024Valence8 US LP6,684$0.34M0.1%N/A0.008%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.655,418$33.49M0.0%+9.8%0.819%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC22,348$1.14M0.0%N/A0.028%Search for SEC Filing on Google Icon
11/8/2024BNP PARIBAS ASSET MANAGEMENT Holding S.A.491,381$25.11M0.1%-10.0%0.614%Search for SEC Filing on Google Icon
11/8/2024Advisors Asset Management Inc.2,806$0.14M0.0%+56.1%0.004%Search for SEC Filing on Google Icon
11/8/2024Connor Clark & Lunn Investment Management Ltd.20,633$1.05M0.0%+2.5%0.026%Search for SEC Filing on Google Icon
11/8/2024Jennison Associates LLC2,793,614$142.75M0.1%+0.5%3.490%Search for SEC Filing on Google Icon
11/8/2024Commerce Bank4,155$0.21M0.0%N/A0.005%Search for SEC Filing on Google Icon
11/7/2024First Turn Management LLC353,376$18.06M2.9%-4.3%0.441%Search for SEC Filing on Google Icon
11/7/2024Swiss National Bank130,900$6.69M0.0%+0.5%0.164%Search for SEC Filing on Google Icon
11/6/2024Natixis Advisors LLC44,346$2.27M0.0%+36.6%0.055%Search for SEC Filing on Google Icon
11/6/2024KBC Group NV2,193$0.11M0.0%+22.8%0.003%Search for SEC Filing on Google Icon
11/6/2024Oppenheimer & Co. Inc.5,469$0.28M0.0%+16.4%0.007%Search for SEC Filing on Google Icon
11/6/2024Oppenheimer Asset Management Inc.4,216$0.22M0.0%N/A0.005%Search for SEC Filing on Google Icon
11/5/2024Victory Capital Management Inc.343,344$17.55M0.0%+51.5%0.429%Search for SEC Filing on Google Icon
11/4/2024Lisanti Capital Growth LLC108,575$5.55M1.4%+30.2%0.136%Search for SEC Filing on Google Icon
11/4/2024State of New Jersey Common Pension Fund D37,341$1.91M0.0%-8.0%0.047%Search for SEC Filing on Google Icon
11/1/2024Assetmark Inc.17,147$0.88M0.0%+13.4%0.021%Search for SEC Filing on Google Icon
11/1/2024Fiera Capital Corp466,075$23.82M0.1%-3.0%0.582%Search for SEC Filing on Google Icon
11/1/2024Lewis Asset Management LLC12,175$0.62M0.5%-1.8%0.015%Search for SEC Filing on Google Icon
10/31/2024Principal Financial Group Inc.77,709$3.97M0.0%+488.5%0.099%Search for SEC Filing on Google Icon
10/28/2024US Bancorp DE11,488$0.59M0.0%+3.4%0.015%Search for SEC Filing on Google Icon
10/25/2024China Universal Asset Management Co. Ltd.15,393$0.79M0.1%+66.1%0.020%Search for SEC Filing on Google Icon
10/25/2024abrdn plc35,467$1.81M0.0%-46.4%0.045%Search for SEC Filing on Google Icon
10/23/2024Mirae Asset Global Investments Co. Ltd.2,895$0.15M0.0%+23.0%0.004%Search for SEC Filing on Google Icon
10/23/2024Values First Advisors Inc.1,644$84K0.0%N/A0.002%Search for SEC Filing on Google Icon
10/23/2024Moody Aldrich Partners LLC139,130$7.11M1.3%-7.4%0.176%Search for SEC Filing on Google Icon
10/23/2024Hennion & Walsh Asset Management Inc.40,835$2.09M0.1%-1.2%0.052%Search for SEC Filing on Google Icon
10/19/2024Allspring Global Investments Holdings LLC1,786$91K0.0%N/A0.002%Search for SEC Filing on Google Icon
10/11/2024Creative Planning19,808$1.01M0.0%+52.4%0.025%Search for SEC Filing on Google Icon
10/5/2024Handelsbanken Fonder AB19,000$0.97M0.0%+15.9%0.024%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC12,963$0.66M0.0%-83.6%0.016%Search for SEC Filing on Google Icon
8/20/2024Novo Holdings A S1,000,000$44.79M2.2%-9.0%1.268%Search for SEC Filing on Google Icon
8/20/2024Senator Investment Group LP135,000$6.05M0.3%N/A0.171%Search for SEC Filing on Google Icon
8/19/2024Point72 Asset Management L.P.2,780,856$124.56M0.3%-43.8%3.474%Search for SEC Filing on Google Icon
8/16/2024Creative Planning12,997$0.58M0.0%+20.6%0.016%Search for SEC Filing on Google Icon
8/16/2024Algert Global LLC41,707$1.87M0.1%+19.0%0.053%Search for SEC Filing on Google Icon
8/16/2024Driehaus Capital Management LLC6,112,173$273.76M2.6%+17.0%7.751%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company131,063$5.87M0.0%+21.7%0.166%Search for SEC Filing on Google Icon
8/15/2024Maplelane Capital LLC160,000$7.17M0.2%N/A0.203%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC7,126$0.32M0.0%+3.3%0.009%Search for SEC Filing on Google Icon
8/15/2024Affinity Asset Advisors LLC515,000$23.07M2.7%+9.6%0.653%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC27,004$1.21M0.0%-21.0%0.034%Search for SEC Filing on Google Icon
8/14/2024Point72 Asset Management L.P.2,780,856$124.56M0.3%-43.8%3.526%Search for SEC Filing on Google Icon
8/14/2024First Light Asset Management LLC1,200,508$53.77M4.7%-29.0%1.522%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP141,204$6.33M0.0%N/A0.179%Search for SEC Filing on Google Icon
8/14/2024Farallon Capital Management LLC497,000$22.26M0.1%+9,840.0%0.630%Search for SEC Filing on Google Icon
8/14/2024Xponance Inc.4,930$0.22M0.0%N/A0.006%Search for SEC Filing on Google Icon
8/14/2024Integral Health Asset Management LLC400,000$17.92M1.7%+23.1%0.507%Search for SEC Filing on Google Icon
8/14/2024Hood River Capital Management LLC410,342$18.38M0.4%N/A0.520%Search for SEC Filing on Google Icon
8/14/2024HighVista Strategies LLC35,237$1.58M0.6%+121.6%0.045%Search for SEC Filing on Google Icon
8/14/2024ProShare Advisors LLC13,704$0.61M0.0%-18.1%0.017%Search for SEC Filing on Google Icon
8/14/2024Profund Advisors LLC21,467$0.96M0.0%-37.4%0.027%Search for SEC Filing on Google Icon
8/13/2024Ensign Peak Advisors Inc616,227$27.60M0.1%-0.8%0.781%Search for SEC Filing on Google Icon
8/13/2024Sei Investments Co.36,973$1.66M0.0%+24.6%0.047%Search for SEC Filing on Google Icon
8/13/2024Public Employees Retirement Association of Colorado9,008$0.40M0.0%-15.5%0.011%Search for SEC Filing on Google Icon
8/12/2024Resolute Capital Asset Partners LLC30,000$1.34M0.8%+50.0%0.038%Search for SEC Filing on Google Icon
8/12/2024Seven Eight Capital LP8,150$0.37M0.0%-60.3%0.010%Search for SEC Filing on Google Icon
8/12/2024Hsbc Holdings PLC10,948$0.48M0.0%+59.2%0.014%Search for SEC Filing on Google Icon
8/12/2024Amalgamated Bank2,692$0.12M0.0%+20.8%0.003%Search for SEC Filing on Google Icon
8/12/2024E Fund Management Co. Ltd.6,813$0.31M0.0%-33.5%0.009%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP546,759$24.49M0.0%-14.7%0.693%Search for SEC Filing on Google Icon
8/8/2024Envestnet Asset Management Inc.51,791$2.32M0.0%+23.5%0.066%Search for SEC Filing on Google Icon
8/8/2024Federated Hermes Inc.15,768$0.71M0.0%+353.5%0.020%Search for SEC Filing on Google Icon
8/8/2024First Turn Management LLC369,302$16.54M2.7%N/A0.468%Search for SEC Filing on Google Icon
8/8/2024Nicholas Investment Partners LP53,012$2.37M0.2%N/A0.067%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.11,178$0.50M0.0%-11.0%0.014%Search for SEC Filing on Google Icon
8/8/2024State of New Jersey Common Pension Fund D40,599$1.82M0.0%-43.7%0.051%Search for SEC Filing on Google Icon
8/7/2024Pier Capital LLC108,545$4.86M0.7%-6.9%0.138%Search for SEC Filing on Google Icon
8/6/2024Quest Partners LLC934$42K0.0%N/A0.001%Search for SEC Filing on Google Icon
8/5/2024Arizona State Retirement System18,543$0.83M0.0%+5.4%0.024%Search for SEC Filing on Google Icon
8/5/2024Victory Capital Management Inc.226,687$10.15M0.0%-11.8%0.287%Search for SEC Filing on Google Icon
8/3/2024TD Asset Management Inc204,998$9.18M0.0%-12.8%0.260%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Crinetics Pharmaceuticals logo
Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate is paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist, which is in Phase 3 trial for the treatment of acromegaly; and Phase 2 trial for treating carcinoid syndrome associated with neuroendocrine tumors. It is also developing CRN04894, an investigational oral nonpeptide product candidate to antagonize the adrenocorticotrophic hormone (ACTH) receptor that has completed a Phase 1 study for the treatment of diseases caused by excess ACTH, including congenital adrenal hyperplasia and Cushing's disease. In addition, the company is developing antagonists of the parathyroid hormone (PTH) receptor for the treatment of primary hyperparathyroidism and humoral hypercalcemia of malignancy, and other diseases of excess PTH; identified investigational orally available somatostatin receptor type 3 targeted nonpeptide agonists for the treatment of autosomal dominant polycystic kidney disease; and developing thyroid-stimulating hormone receptor antagonists for the treatment of graves' disease and thyroid eye disease, as well as Oral GLP-1 and GIP nonpeptides for the treatment of diabetes and obesity. Crinetics Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in San Diego, California.
Read More on Crinetics Pharmaceuticals

Today's Range

Now: $54.72
Low: $54.42
High: $60.15

50 Day Range

MA: $54.97
Low: $49.82
High: $60.69

52 Week Range

Now: $54.72
Low: $27.55
High: $62.53

Volume

908,800 shs

Average Volume

785,381 shs

Market Capitalization

$5.07 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.62

Who are the company insiders with the largest holdings of Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals' top insider investors include:
  1. Richard Scott Struthers (CEO)
  2. Marc Wilson (CFO)
  3. Stephen F Betz (Insider)
  4. Jeff E Knight (COO)
  5. Alan Seth Krasner (Insider)
  6. James Hassard (Insider)
  7. Dana Pizzuti (Insider)
  8. Matthew K Fust (Director)
  9. Stephanie Okey (Director)
  10. Coelho Rogerio Vivaldi (Director)
Learn More about top insider investors at Crinetics Pharmaceuticals.

Who are the major institutional investors of Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals' top institutional investors include:
  1. Wellington Management Group LLP — 4.81%
  2. FMR LLC — 5.57%
  3. State Street Corp — 3.06%
  4. Jennison Associates LLC — 3.49%
  5. Janus Henderson Group PLC — 2.62%
  6. Point72 Asset Management L.P. — 2.48%
Learn More about top institutional investors of Crinetics Pharmaceuticals stock.

Which institutional investors are selling Crinetics Pharmaceuticals stock?

During the previous quarter, CRNX stock was sold by these institutional investors:
  1. Point72 Asset Management L.P.
  2. Ikarian Capital LLC
  3. Wellington Management Group LLP
  4. SG Americas Securities LLC
  5. Parkman Healthcare Partners LLC
  6. BNP PARIBAS ASSET MANAGEMENT Holding S.A.
  7. abrdn plc
  8. Janus Henderson Group PLC
During the last year, company insiders that have sold Crinetics Pharmaceuticals company stock include:
  1. Richard Scott Struthers (CEO)
  2. Marc Wilson (CFO)
  3. Stephen F Betz (Insider)
  4. Jeff E Knight (COO)
  5. Alan Seth Krasner (Insider)
  6. James Hassard (Insider)
  7. Dana Pizzuti (Insider)
  8. Matthew K Fust (Director)
Learn More investors selling Crinetics Pharmaceuticals stock.

Which institutional investors are buying Crinetics Pharmaceuticals stock?

In the last quarter, CRNX stock was bought by institutional investors including:
  1. FMR LLC
  2. Vestal Point Capital LP
  3. Geode Capital Management LLC
  4. Victory Capital Management Inc.
  5. Barclays PLC
  6. Castleark Management LLC
  7. Principal Financial Group Inc.
  8. Charles Schwab Investment Management Inc.